Verteporfin-Mediated In Situ Nanovaccine Based on Local Conventional-Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect.

Adv Sci (Weinh) · 2025 · PMC12120762 · PMID 40231790

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an evident trendno p-value reported

Both 2 Gy and N@VP + 2 Gy treatment displayed an evident trend toward upregulating the ratio of IFN‐γ to IL‐4 expressed by CD3 + CD4 + T cells, indicating a significant Th1‐mediated antitumor immune responses activation (Figure 5c ).

also in 78 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.